Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer
Gastric & Breast Cancer
DOI: 10.2122/gbc.2002.0001


Gastric Cancer: Introduction, Pathology, Epidemiology

Dimitrios H. Roukos, MD, Niki J. Agnantis, MD, Michael Fatouros, MD, and Angelos M. Kappas, MD
From the Departments of Surgery (DHR, MF, AMK) and Pathology (NJA), Ioannina University School of Medicine, 45110 Ioannina, Greece,


Gastric carcinoma is a malignant disease, which starts in the stomach. Despite declining incidence still remains the second cause of death of all malignancies worldwide. It is a major health problem for two reasons: In Asia, East Europe and developing countries the incidence decreases slowly. In USA and West Europe although incidence decreases sharply, mortality of diagnosed gastric cancer remains high.
Adenocarcinoma of the stomach still remains a major health problem. There has been an decrease in incidence of this cancer worldwide but the degree of this reduction varies considerably among different geographical areas.

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 22 May 2003